Equillium Stock Price To Sales

EQ Stock

USD 0.74 0.03 4.23%

Equillium fundamentals help investors to digest information that contributes to Equillium's financial success or failures. It also enables traders to predict the movement of Equillium Stock. The fundamental analysis module provides a way to measure Equillium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Equillium stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	0.70	0.66

As of 11/25/2024, Price To Sales Ratio is likely to drop to 0.66.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Equillium Company Price To Sales Analysis

Equillium's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Equillium Price To Sales

0.59 X

Most of Equillium's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Equillium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Equillium Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Equillium is extremely important. It helps to project a fair market value of Equillium Stock properly, considering its historical fundamentals such as Price To Sales. Since Equillium's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Equillium's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Equillium's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Capital Surpluse	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Capital Stock	Intangible Assets	Current Deferred Revenue
Total Assets		0.92	0.96	-0.87	-0.73	0.73	-0.38	0.65	0.9	0.55	0.76	-0.91	1.0	0.9	-0.85	0.81	0.52	0.69	0.8	0.29
Total Stockholder Equity	0.92		0.96	-0.71	-0.44	0.51	-0.34	0.56	0.75	0.24	0.8	-0.95	0.92	0.99	-0.82	0.59	0.19	0.43	0.64	0.02
Net Tangible Assets	0.96	0.96		-0.75	-0.6	0.62	-0.37	0.69	0.82	0.31	0.79	-0.97	0.96	0.92	-0.92	0.69	0.39	0.55	0.71	0.29
Net Debt	-0.87	-0.71	-0.75		0.79	-0.7	0.59	-0.55	-0.87	-0.72	-0.46	0.64	-0.86	-0.7	0.6	-0.82	-0.63	-0.76	-0.67	-0.26
Retained Earnings	-0.73	-0.44	-0.6	0.79		-0.9	0.37	-0.66	-0.89	-0.85	-0.33	0.49	-0.73	-0.39	0.66	-0.95	-0.94	-0.96	-0.85	-0.67
Accounts Payable	0.73	0.51	0.62	-0.7	-0.9		-0.48	0.7	0.9	0.82	0.56	-0.52	0.73	0.47	-0.67	0.96	0.85	0.94	0.89	0.48
Long Term Debt	-0.38	-0.34	-0.37	0.59	0.37	-0.48		-0.54	-0.42	-0.3	-0.42	0.25	-0.38	-0.27	0.31	-0.44	-0.45	-0.4	-0.14	-0.17
Long Term Debt Total	0.65	0.56	0.69	-0.55	-0.66	0.7	-0.54		0.69	0.34	0.53	-0.7	0.65	0.47	-0.85	0.66	0.63	0.57	0.66	0.57
Capital Surpluse	0.9	0.75	0.82	-0.87	-0.89	0.9	-0.42	0.69		0.74	0.55	-0.73	0.89	0.72	-0.79	0.97	0.71	0.91	0.93	0.36
Total Liab	0.55	0.24	0.31	-0.72	-0.85	0.82	-0.3	0.34	0.74		0.21	-0.2	0.55	0.26	-0.27	0.83	0.8	0.87	0.73	0.31
Net Invested Capital	0.76	0.8	0.79	-0.46	-0.33	0.56	-0.42	0.53	0.55	0.21		-0.79	0.77	0.79	-0.69	0.48	0.23	0.34	0.51	0.08
Short Long Term Debt	-0.91	-0.95	-0.97	0.64	0.49	-0.52	0.25	-0.7	-0.73	-0.2	-0.79		-0.91	-0.92	0.92	-0.58	-0.27	-0.42	-0.68	-0.23
Total Current Assets	1.0	0.92	0.96	-0.86	-0.73	0.73	-0.38	0.65	0.89	0.55	0.77	-0.91		0.9	-0.85	0.8	0.52	0.68	0.8	0.29
Net Working Capital	0.9	0.99	0.92	-0.7	-0.39	0.47	-0.27	0.47	0.72	0.26	0.79	-0.92	0.9		-0.75	0.56	0.12	0.4	0.63	-0.09
Short Term Debt	-0.85	-0.82	-0.92	0.6	0.66	-0.67	0.31	-0.85	-0.79	-0.27	-0.69	0.92	-0.85	-0.75		-0.7	-0.51	-0.58	-0.76	-0.51
Common Stock	0.81	0.59	0.69	-0.82	-0.95	0.96	-0.44	0.66	0.97	0.83	0.48	-0.58	0.8	0.56	-0.7		0.83	0.98	0.92	0.46
Property Plant Equipment	0.52	0.19	0.39	-0.63	-0.94	0.85	-0.45	0.63	0.71	0.8	0.23	-0.27	0.52	0.12	-0.51	0.83		0.88	0.67	0.79
Capital Stock	0.69	0.43	0.55	-0.76	-0.96	0.94	-0.4	0.57	0.91	0.87	0.34	-0.42	0.68	0.4	-0.58	0.98	0.88		0.87	0.51
Intangible Assets	0.8	0.64	0.71	-0.67	-0.85	0.89	-0.14	0.66	0.93	0.73	0.51	-0.68	0.8	0.63	-0.76	0.92	0.67	0.87		0.38
Current Deferred Revenue	0.29	0.02	0.29	-0.26	-0.67	0.48	-0.17	0.57	0.36	0.31	0.08	-0.23	0.29	-0.09	-0.51	0.46	0.79	0.51	0.38

Click cells to compare fundamentals

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Equillium

Price To Sales Ratio Over Time

Based on the latest financial disclosure, Equillium has a Price To Sales of 0.591 times. This is 97.24% lower than that of the Biotechnology sector and 99.4% lower than that of the Health Care industry. The price to sales for all United States stocks is 94.82% higher than that of the company.

Equillium Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Equillium's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Equillium could also be used in its relative valuation, which is a method of valuing Equillium by comparing valuation metrics of similar companies.

Equillium is currently under evaluation in price to sales category among its peers.

Equillium Current Valuation Drivers

We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	58.7M	108.9M	108.6M	35.8M	25.1M	23.9M
Enterprise Value	55.2M	93.2M	68.2M	(13.2M)	2.7M	2.6M

Equillium Fundamentals

	Return On Equity	-0.34
	Return On Asset	-0.12
	Profit Margin	(0.20) %
	Operating Margin	(0.01) %
	Current Valuation	(188.73 K)
	Shares Outstanding	35.43 M
	Shares Owned By Insiders	36.20 %
	Shares Owned By Institutions	20.03 %
	Number Of Shares Shorted	117.56 K
	Price To Earning	(6.70) X
	Price To Book	1.09 X
	Price To Sales	0.59 X
	Revenue	36.08 M
	Gross Profit	15.76 M
	EBITDA	(12.14 M)
	Net Income	(13.34 M)
	Cash And Equivalents	57.56 M
	Cash Per Share	1.68 X
	Total Debt	824 K
	Debt To Equity	0.29 %
	Current Ratio	3.98 X
	Book Value Per Share	0.64 X
	Cash Flow From Operations	(21.78 M)
	Short Ratio	0.53 X
	Earnings Per Share	(0.12) X
	Target Price	3.33
	Number Of Employees	45
	Beta	1.83
	Market Capitalization	25.19 M
	Total Asset	50.53 M
	Retained Earnings	(185.74 M)
	Working Capital	21.78 M
	Current Asset	60.04 M
	Current Liabilities	1.81 M
	Net Asset	50.53 M

About Equillium Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Equillium

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.

Moving against Equillium Stock

0.57	RNXT	RenovoRx	Pair Corr
0.55	MDGL	Madrigal Pharmaceuticals	Pair Corr

The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.

The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Equillium Stock Analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC